FDA Brief

Warning letters Food

FDA warning letter to

Infusionz, LLC

High riskIssued Nov 16, 2022Posted Nov 21, 2022Center for Food Safety and Applied Nutrition (CFSAN)

Infusionz sells CBD candies, gummies, tinctures and pet products that FDA calls adulterated and illegally marketed.

What happened

FDA reviewed cbdinfusionz.com in October 2022 and the company’s Facebook and Instagram pages, which direct consumers to the website to buy products represented as containing CBD. FDA said it analyzed samples of the gummy, gum and lollipop products and confirmed they contain CBD. FDA determined the CBD gummies, fruit snacks, gum, candy, oil/tinctures and lollipops are adulterated foods containing an unsafe food additive and are prohibited in interstate commerce, and it also raised concerns about CBD dog treats and tincture marketed for animal conditions.

What FDA found

  1. The CBD gummies, fruit snacks, gum, candy, oil/tinctures, and lollipops are foods with added CBD, which FDA treats as an unsafe food additive because CBD is not approved for use in conventional food.

    FD&C Act § 402(a)(2)(C)(i), 21 U.S.C. 342(a)(2)(C)(i); § 409(a), 21 U.S.C. 348(a)
  2. Selling those CBD foods across state lines is prohibited because CBD is the active ingredient in an approved drug and substantial clinical investigations of CBD have been made public.

    FD&C Act § 301(ll), 21 U.S.C. 331(ll)
  3. Selling adulterated food across state lines is prohibited.

    FD&C Act § 301(a), 21 U.S.C. 331(a)
  4. The CBD dog treats and hemp CBD tincture are marketed for animal conditions such as separation anxiety, noise aversion, and seizures, and CBD is not an approved food additive or GRAS for animal food.

    21 CFR 570.30

What FDA wants

FDA asks Infusionz to notify it in writing within 15 working days of the steps taken to address the violations, including how it will prevent recurrence and copies of related documents. If corrective actions cannot be completed in that time, the company must state why and give a timeframe.

Who should pay attention

  • retailers and online marketplaces selling CBD foods
  • brands using CBD in conventional foods or pet products
  • contract manufacturers of CBD gummies, candy, and tinctures

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Trew Balance

    FDA warned Trew Balance that its Trew Vision CBD Eye Drops are an unapproved new drug sold with disease-treatment claims.

    High risk
  2. Bailey’s Wellness, LLC dba Bailey’s CBD

    Bailey’s CBD markets CBD animal and human products with unapproved drug claims, including products for food-producing animals.

    High risk
  3. House of Alchemy LLC dba CBD Dog Health Hamet & Love LLC dba MycoDog

    FDA warned CBD Dog Health and MycoDog their CBD and mushroom pet products are unapproved animal drugs, citing disease-treatment claims online.

    High risk
  4. Holista LLC dba HolistaPet

    FDA warned HolistaPet that its CBD animal products are unapproved new animal drugs and adulterated animal food.

    High risk